Institutional investors purchased a net $46.9 thousand shares of MNOV during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 18.22% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 932.9 Thousand shares of MediciNova Inc
SSGA FUNDS MANAGEMENT, INC. Bought 378.1 Thousand shares of MediciNova Inc
NORTHERN TRUST INVESTMENTS, INC. Bought 276.7 Thousand shares of MediciNova Inc